Dutch pharmaceutical contract packaging organisation Tjoapack is to strengthen its blistering capabilities by adding its eighth line, which is expected to bring late-stage customisation printing benefits.

Tjoapack said the line will be operational at its facility in Etten-Leur, Netherlands, by the end of the third quarter of this year.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The company said in a statement: “At Tjoapack we are committed to ensuring our customers continue to receive the efficient and flexible service that they are used to, so we are always looking for ways to further improve our operations to allow us to better cater for their projects.

“We have a strategic growth plan in place and increasing our blistering capacity will allow us to cater for increasing demand from both current and new customers.”

The investment will also enable the company to expand its existing postponement printing offering and include drop-on-demand digital printing services for blisters.

“We have a strategic growth plan in place and increasing our blistering capacity will allow us to cater for increasing demand from both current and new customers.”

According to Tjoapack, late-stage customisation offers certain advantages to the pharmaceutical supply chain as it reduces waste from repackaging, overall costs and time to market.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The company stated: “We have started to explore this type of packaging with some of our customers already and as more complex molecules continue to enter the drug pipeline, demand for last-minute packaging is likely to increase.

“This investment will allow us to futureproof our lines for projected demands.”

Established in 1989, the company is engaged in primary packaging for solid dosage forms, secondary packaging and unit dose packaging.

Operating a total of 19 packaging lines for blisters, wallets and bottles, the company caters to the demands of clients across five continents and 42 countries.